Gene · 3326
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Replication Compartments-The Great Survival Strategy for Epstein-Barr Virus Lytic Replication. | Microorganisms | 2022 | 35630341 | PubTator, text mining | PubMed |
| Functional Properties of Cancer Epithelium and Stroma-Derived Exosomes in Head and Neck Squamous Cell Carcinoma. | Life (Basel) | 2022 | 35629423 | PubTator, text mining | PubMed |
| Impact of Storage Conditions on EV Integrity/Surface Markers and Cargos. | Life (Basel) | 2022 | 35629364 | PubTator, text mining | PubMed |
| Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome. | Int J Mol Sci | 2022 | 35628184 | PubTator, text mining | PubMed |
| Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia. | Genes (Basel) | 2022 | 35627268 | PubTator, text mining | PubMed |
| Revisiting the Old Data of Heat Shock Protein 27 Expression in Squamous Cell Carcinoma: Enigmatic HSP27, More Than Heat Shock. | Cells | 2022 | 35626702 | PubTator, text mining | PubMed |
| Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors. | Cancers (Basel) | 2022 | 35626148 | PubTator, text mining | PubMed |
| Parkinson's Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment. | Biomedicines | 2022 | 35625737 | PubTator, text mining | PubMed |
| Advances towards Understanding the Mechanism of Action of the Hsp90 Complex. | Biomolecules | 2022 | 35625528 | PubTator, text mining | PubMed |
| The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification. | Exp Hematol Oncol | 2022 | 35624462 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveals diverse stimuli activate distinct signaling pathways during neutrophil activation. | Cell Tissue Res | 2022 | 35622142 | PubTator, text mining | PubMed |
| N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through YTHDF3 Modulating Macrophage Polarization. | Front Cardiovasc Med | 2022 | 35620523 | PubTator, text mining | PubMed |
| Identification of Cytoplasmic Chaperone Networks Relevant for Respiratory Syncytial Virus Replication. | Front Microbiol | 2022 | 35615506 | PubTator, text mining | PubMed |
| Serotonin limits generation of chromaffin cells during adrenal organ development. | Nat Commun | 2022 | 35614045 | PubTator, text mining | PubMed |
| Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils. | Clin Exp Metastasis | 2022 | 35604506 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Uncovers Cellular Heterogeneity, Mechanisms, and Therapeutic Targets for Parkinson's Disease. | Front Genet | 2022 | 35601482 | PubTator, text mining | PubMed |
| Juvenile Hormone Membrane Signaling Enhances its Intracellular Signaling Through Phosphorylation of Met and Hsp83. | Front Physiol | 2022 | 35574494 | PubTator, text mining | PubMed |
| Study on the Expression Profile of Autophagy-Related Genes in Colon Adenocarcinoma. | Comput Math Methods Med | 2022 | 35572821 | PubTator, text mining | PubMed |
| Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients. | Front Immunol | 2022 | 35572591 | PubTator, text mining | PubMed |
| Regulation of SLC6A14 trafficking in breast cancer cells by heat shock protein HSP90β. | Biochem Biophys Res Commun | 2022 | 35569376 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3326/papers?page=52